Washington DC Cancer Support

If you live, work or travel in or around Washington, D.C and you are living with cancer – either as a patient or caregiver, then you need this information.

Smith Farms offers incredible free and financially assisted day, weekend and weeklong retreats designed to strengthen your innate healing mechanisms as you learn to balance mainstream medical treatment with your own desire to live a healthier, more fulfilling life. The integrated schedule provides support sessions, yoga, meditation, deep relaxation, imagery work, creativity sessions, a gourmet vegetarian meal and discussions on choices among complementary and conventional cancer therapies.

In addition to retreats and programs at the Center, they provide resources in the Washington, DC community at large. Our hospital-based Artist-in-Residence programs engage patients in creative arts activities as part of the healing process through the visual arts, creative writing, storytelling, music, creative movement, and guided imagery.

Also, by training breast cancer survivors as Patient Navigators, Smith Farm offers individual counseling and education to improve access to care and enhance the treatment experience of underserved communities. Patient Navigators guide cancer patients through treatment while offering psychosocial support to individuals and their families.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap